Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01388777 | Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT02455882 | Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer | terminated | — | 14 | University of MichiganOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00088829 | Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | terminated | Phase 2 | 22 | Georgetown UniversityOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01009983 | Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer | terminated | Phase 2 | 14 | Wake Forest University Health SciencesOTHER | 1 | Jul 6, 2018 | clinicaltrials |
| NCT02023008 | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | terminated | N/A | 6 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02331251 | Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) | terminated | Phase 1 / Phase 2 | 81 | Western Regional Medical CenterOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01580800 | National Breast Cancer and Lymphedema Registry | terminated | — | 549 | Stanley RocksonOTHER | 1 | Jun 29, 2018 | clinicaltrials |
| NCT03407430 | Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | terminated | Phase 2 | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT02281812 | Radiofrequency Ablation in Breast Cancer | terminated | N/A | 40 | Hospital Universitari de BellvitgeOTHER | 1 | Jun 4, 2018 | clinicaltrials |
| NCT00827580 | Eniluracil Hand Foot Syndrome | terminated | Phase 1 | 3 | West Virginia UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT02524951 | Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer | terminated | Phase 1 | 5 | Northwell HealthOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT02112682 | Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy | terminated | N/A | 52 | Maastricht University Medical CenterOTHER | 1 | May 9, 2018 | clinicaltrials |
| NCT01776008 | Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer | terminated | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 8, 2018 | clinicaltrials |
| NCT02543645 | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | terminated | Phase 1 | 18 | Celldex TherapeuticsINDUSTRY | 1 | Apr 30, 2018 | clinicaltrials |
| NCT02379585 | Fasting on Newly Diagnosed Breast Cancer(STEFNE) | terminated | Phase 1 / Phase 2 | 8 | Western Regional Medical CenterOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT00898937 | Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast | terminated | — | 55 | Georgetown UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT02365714 | CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)(CK-SAPBI) | terminated | Phase 1 / Phase 2 | 2 | Georgetown UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT00824538 | Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | terminated | Phase 2 | 13 | University of California, San FranciscoOTHER | 0 | Apr 5, 2018 | clinicaltrials |
| NCT02677857 | Developing a Healthy Lifestyle in Breast Cancer Survivors | terminated | N/A | 7 | The University of Tennessee, KnoxvilleOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02708511 | Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer | terminated | Phase 1 | 2 | Sanjiv Sam GambhirOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00504699 | Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients | terminated | N/A | 120 | New York Medical CollegeOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT02771444 | Low Dose Tomosynthesis Compared to Traditional Tomosynthesis | terminated | N/A | 17 | Philips Digital Mammography Sweden ABINDUSTRY | 1 | Mar 26, 2018 | clinicaltrials |
| NCT00692692 | Use of Dermal Matrix in Breast Reconstruction | terminated | N/A | 36 | Vanderbilt UniversityOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT01010854 | Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer(VPA-FEC100) | terminated | Phase 2 | 6 | University of California, San FranciscoOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT00352872 | Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer | terminated | — | 23 | Indiana UniversityOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT02596867 | Neoadjuvant Propanolol in Breast Cancer(NPBC) | terminated | Phase 2 | 2 | Texas Tech University Health Sciences Center, El PasoOTHER | 1 | Mar 1, 2018 | clinicaltrials |
| NCT00722072 | Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy | terminated | Phase 2 | 12 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03202446 | Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | terminated | Phase 3 | 18 | Eske Corporation S.A.CINDUSTRY | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00004261 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | terminated | Phase 1 | — | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT01698281 | Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer | terminated | Phase 2 | 7 | AEterna ZentarisINDUSTRY | 2 | Feb 22, 2018 | clinicaltrials |
| NCT01887288 | Capecitabine With Digoxin for Metastatic Breast Cancer | terminated | Phase 2 | 16 | Western Regional Medical CenterOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT02345772 | Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy(Neohttp) | terminated | Phase 1 / Phase 2 | 4 | Western Regional Medical CenterOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT00632541 | A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer | terminated | Phase 2 | 18 | Hoosier Cancer Research NetworkOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT02120417 | A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer | terminated | Phase 2 | 149 | Incyte CorporationINDUSTRY | 6 | Feb 13, 2018 | clinicaltrials |
| NCT01484041 | Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 12 | Georgetown UniversityOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Western Regional Medical CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT00095862 | Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers | terminated | Phase 1 / Phase 2 | 24 | Wiseman Research Initiatives LLCINDUSTRY | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02257775 | Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer(EVOLUTION) | terminated | — | 5 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT01817374 | Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy | terminated | N/A | 6 | University of Alabama at BirminghamOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00873366 | Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer | terminated | — | 92 | Mayo ClinicOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01655992 | A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) | terminated | Phase 3 | 386 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01984892 | Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)(Hiltonol) | terminated | Phase 2 | 8 | Nina BhardwajOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02166658 | A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)(CaBaMet) | terminated | Phase 2 | 8 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02348281 | Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients | terminated | Phase 2 | 1 | Fudan UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00864175 | Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 68 | Incyte CorporationINDUSTRY | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01929941 | An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies | terminated | Phase 1 | 5 | Incyte CorporationINDUSTRY | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01815346 | Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG | terminated | Phase 1 / Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 49 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Jul 17, 2018source: clinicaltrials